Clinical Trials Sponsored by Micell Technologies

Total 2210 results

Paragonix Technologies

Enrolling by invitation

Global Utilization And Registry Database for Improved heArt preservatioN (GUARDIAN)

Heart Diseases | Heart Failure | Heart Defects, Congenital

United States, Spain, Austria, United Kingdom
Bloom Technologies

Completed

A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring (NST)

Fetal Monitoring

United States
Cardiologs Technologies

Completed

Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG

Atrial Fibrillation

United States
Bloom Technologies

Completed

A Clinical Study to Investigate the Reliability of Fetal Heart Rate and Maternal Heart Rate Signals Extracted From Biopotential Data

Pregnancy Related

United States
Alung Technologies

Terminated

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD (VENT-AVOID)

Acute Exacerbation of COPD

United States
DBV Technologies

Completed

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children (OLFUS-VIPES)

Peanut Allergy

United States, Netherlands, France, Canada
Cardiologs Technologies

Completed

Observational Clinical Investigation of EKG Diagnostic Performance of the Apple Watch Augmented With an AI Algorithm

Atrial Fibrillation

France
Bloom Technologies

Completed

Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring

Foetal Wellbeing

Belgium
Cardiologs Technologies

Completed

Exploratory Study of Apple Watch Electrocardiographic Diagnostic Performance Enhanced by an Artificial Intelligence Algorithm

Atrial Fibrillation

France
DBV Technologies

Active, not recruiting

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children (PEOPLE)

Peanut Allergy

United States, Germany, Canada, Australia, Ireland
Alung Technologies

Completed

Feasibility Study of the Hemolung Respiratory Assist System (Germany)

Hypercapnic Respiratory Failure, COPD, ARDS

Germany
Bloom Technologies

Completed

Investigating the Physiology of Labour and Labour Onset Through Longitudinal Measurements Performed With a Wearable Sensor

Labour Onset

Belgium
Stimwave Technologies

Completed

Stimwave HF SCS Pilot Study (HFSCS)

FBSS

Belgium
AVAX Technologies

Terminated

DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer - Completely Resectable

United States
AVAX Technologies

Terminated

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
AVAX Technologies

Unknown

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Adenocarcinoma of the Ovary

United States
Facet Technologies

Completed

Lancet Blood Volume Comparison Study

Diabetes

United States
VisionScope Technologies

Completed

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee (VSI-001)

Meniscus Tears | Loose Bodies | Articular Osteoarthritis | Articular or Capsular Trauma

United States
Facet Technologies

Completed

Lancing Device Comparison Study

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
Neurokeeper Technologies

Unknown

Validation of an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS

Stroke

Israel
Neurokeeper Technologies

Unknown

Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.

Stroke

Israel
FoxHollow Technologies

Terminated

A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease (NightHawk)

Peripheral Vascular Diseases

United States
Genelabs Technologies

Completed

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Systemic Lupus Erythematosus

United States, Mexico
Northgate Technologies

Unknown

Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.

Pneumoperitoneum | Obesity | Pain, Postoperative | Postoperative Pain | Abdominal Pain

United States
Heartfelt Technologies

Not yet recruiting

Randomised Controlled Trial for Assessing the Effectiveness of an Inclusive Heart Failure Monitoring and TRACKing Solution in the UK. (HF-TRACK)

Heart Failure

United Kingdom
Cardiologs Technologies

Completed

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

Atrial Fibrillation | Bradycardia | Tachycardia | Premature Ventricular Contraction | Premature Supraventricular Beat

United States
HiDO Technologies

Completed

Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS

HIV Infections

United States
Neosense Technologies

Terminated

Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2 (IMPROVE-2)

Lung Diseases | Catheter | Newborn, Infant, Disease

Sweden
Allurion Technologies

Completed

The Allurion Digital Behaviour Change Intervention

Obesity

Netherlands, United Kingdom
Median Technologies

Completed

BICR in New Therapeutic Lung Cancer Trials

Lung Cancer

France
Bloom Technologies

Completed

A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Antepartum Fetal Monitoring (NST)

Fetal Monitoring

Belgium
DBV Technologies

Completed

Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy (PEPITES)

Peanut Allergy

United States, Canada, Germany, Australia, Ireland
DBV Technologies

No longer available

Viaskin® Peanut (DBV712) Expanded Access Protocol

Peanut Allergy
DBV Technologies

Active, not recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age (EPITOPE)

Peanut Allergy

United States, Canada, Australia, France, Germany, United Kingdom, Ireland, Netherlands
DBV Technologies

Completed

Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)

Peanut Allergy

United States, Canada
Alung Technologies

Completed

Feasibility Study of the Hemolung Respiratory Assist System

Hypercapnic Respiratory Failure, COPD

India
Alung Technologies

Withdrawn

Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure

Chronic Obstructive Pulmonary Disease | Respiratory Insufficiency | Asthma | Emphysema | Acute Respiratory Distress Syndrome

United Kingdom
AVAX Technologies

Completed

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Melanoma

United States
Harvest Technologies

Completed

Study of Autologous Bone Marrow Concentrate for the Treatment of Critical Limb Ischemia (CLI)

Ischemia

United States
Harvest Technologies

Terminated

BMAC Enhanced Coronary Artery Bypass Grafting (CABG)

Congestive Heart Failure

India
Neurokeeper Technologies

Unknown

Validation of Neurokeeper's Algorithm on Patients Undergoing Carotid Endarterectomy

Stroke

Israel
Neurokeeper Technologies

Unknown

Electroencephalograph for Detection of Acute Ischemic Stroke

Stroke

Israel
Momelan Technologies

Unknown

Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds

Surgical Wound | Hypo-pigmented Skin

United States
Harvest Technologies

Terminated

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Diabetes

United States
Harvest Technologies

Completed

Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI

Arterial Occlusive Diseases

India
Broncus Technologies

Unknown

EASE Trial: Exhale Airway Stents for Emphysema (EASE)

Emphysema

United States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
Neurobiological Technologies

Terminated

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

United States, Australia, Israel, South Africa, Slovakia, New Zealand, Austria, Czech Republic, Poland, Russian Federation, Switzerland
Neurobiological Technologies

Terminated

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

Taiwan, United States, Australia, South Africa, Canada, Czech Republic, Netherlands, Poland, Russian Federation, United Kingdom
Genelabs Technologies

Unknown

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Lupus

United States, Mexico
Neurotec Pharma
Advancell - Advanced In Vitro Cell Technologies, S.A.

Completed

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Spain, Germany

3

Subscribe